MODULATING INSULIN RECEPTOR SIGNALING THROUGH TARGETING FACL

Details for Australian Patent Application No. 2002357329 (hide)

Owner EXELIXIS, INC.

Inventors O'BRIEN, Carol, L.; KADYK, Lisa, C.

Pub. Number AU-A-2002357329

PCT Number PCT/US02/40565

PCT Pub. Number WO2003/054159

Priority 60/342,429 19.12.01 US

Filing date 18 December 2002

Wipo publication date 9 July 2003

Event Publications

27 March 2003 Complete Application Filed

  Priority application(s): 60/342,429 19.12.01 US

2 October 2003 Application Open to Public Inspection

  Published as AU-A-2002357329

29 June 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002357330-PASSIVE WATER MANAGEMENT FUEL CELL

2002357328-CELL SEARCH USING PEAK QUALITY FACTORS